110. Deputy Imelda Munster asked the Minister for Health the status of the development of the terms of reference, required membership and reporting relationship for the working group to bring forward appropriate decision criteria for the reimbursement of orphan medicines and technologies; the timeline for these actions or when they can be expected; when these will be published; if expert pharmacologic support to advise the chairperson has been provided; and if he will make a statement on the matter. [4555/17]

Summary

110. Deputy Imelda Munster asked the Minister for Health the status of the development of the terms of reference, required membership and reporting relationship for the working group to bring forward appropriate decision criteria for the reimbursement of orphan medicines and technologies; the timeline for these actions or when they can be expected; when these will be published; if expert pharmacologic support to advise the chairperson has been provided; and if he will make a statement on the matter. [4555/17]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Rare Diseases

  xml · EN · 1 February 2017

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.